☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
merck
Merck’s Keytruda Combined with Chemotherapy Receives EC’s Approval for the Treatment of Non-Small Cell Lung Cancer
March 28, 2024
Merck’s Winrevair (sotatercept-csrk) Receives the US FDA’s Approval for the Treatment of Pulmonary Arterial Hypertension (PAH)
March 27, 2024
Merck Reports Data from the P-III (KEYLYNK-006) Study of Keytruda for Treatment of Metastatic Non-squamous NSCLC
March 21, 2024
Merck Highlights Results from Various P-III Trials of V116 Vaccine for Pneumococcal Diseases at ISPPD-13 2024
March 20, 2024
Merck Reports Results from the P-III (KEYNOTE-A18) Study of Keytruda for the Treatment of Cervical Cancer
March 15, 2024
Merck’s Keytruda (pembrolizumab) in Combination with Chemotherapy Receives CHMP’s Positive Opinion for the Treatment of Non-Small...
February 23, 2024
Load more...
Back to Home